title: Virus-related Merkel cell carcinoma complicating fingolimod treatment for multiple sclerosis.
authors.affiliation: From The University of Sydney (H.N.B., A.J.G., S.R., M.H.B.); Royal Prince Alfred Hospital (H.N.B., M.H.B.), Sydney; and Concord Hospital (S.R.), Australia.
authors.forename: Heidi N
authors.initials: HN
authors.lastname: Beadnall
authors.affiliation: From The University of Sydney (H.N.B., A.J.G., S.R., M.H.B.); Royal Prince Alfred Hospital (H.N.B., M.H.B.), Sydney; and Concord Hospital (S.R.), Australia.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Gill
authors.affiliation: From The University of Sydney (H.N.B., A.J.G., S.R., M.H.B.); Royal Prince Alfred Hospital (H.N.B., M.H.B.), Sydney; and Concord Hospital (S.R.), Australia.
authors.forename: Sean
authors.initials: S
authors.lastname: Riminton
authors.affiliation: From The University of Sydney (H.N.B., A.J.G., S.R., M.H.B.); Royal Prince Alfred Hospital (H.N.B., M.H.B.), Sydney; and Concord Hospital (S.R.), Australia. michael@sydneyneurology.com.au.
authors.forename: Michael H
authors.initials: MH
authors.lastname: Barnett
mesh_terms: D015266:Carcinoma, Merkel Cell / Q000276:immunology*; D000068876:Fingolimod Hydrochloride / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008875:Middle Aged; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000276:immunology*
chemical_list: D007166:Immunosuppressive Agents; D000068876:Fingolimod Hydrochloride